Company patents
Cardio Flow, Inc.
Cardio Flow, Inc. exhibits a highly concentrated patent strategy, with 100.0% of its portfolio in Medical Diagnostics & Surgery, showing robust growth of +30.8% in 2025. While Drug Delivery Devices represents a minor 6.5% of its portfolio, the complete cessation of patenting in this area in 2024 and so far in 2026 suggests a significant shift away from this technology.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
46 US filings (since 2023) · 2 categories · 2 themes
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Patents
Showing 1-10 of 57